BridgeMD
New treatment option for Liver Fibrosis
Official title Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel
ClinicalTrials.gov ID: NCT05308628
What this study is testing
- What it's testing
- Liver transplantation in children is highly successful with \>80% having 20 years survival. Most pediatric liver diseases are potentially curable with liver transplantation and it is important to establish whether children who have undergone successful transplantation can expect a normal life expectancy or whether there will be a gradual decline in liver function and eventual graft loss.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 18
You may be able to join if
- Male or female participant must be between 8 weeks and 18 years of age.
- Participant is a recipient of a first liver allograft from cadaveric or living donors.
- Participant is a single-organ recipient (liver only).
- Participants' parent/guardian is capable of understanding the purposes and risks of the study and must sign an informed consent for the study.
You likely can't join if
- Participants older than 18 years of age
- Pregnant or breastfeeding
- Active systemic infections
- Receiving any form of solid organ retransplantation
- Multiorgan transplantation
- Multi organ failure
See the full eligibility criteria
- Male or female participant must be between 8 weeks and 18 years of age.
- Participant is a recipient of a first liver allograft from cadaveric or living donors.
- Participant is a single-organ recipient (liver only).
- Participants' parent/guardian is capable of understanding the purposes and risks of the study and must sign an informed consent for the study.
- Participants older than 18 years of age
- Pregnant or breastfeeding
- Active systemic infections
- Receiving any form of solid organ retransplantation
- Multiorgan transplantation
- Multi organ failure
- Congenital sufferers from heart, lung, kidney, nervous system or blood disease
- Refused to participate the study
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 months to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.